The global Malaria Rapid Diagnostic Devices Market Study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Category (Consumables, Systems), By Application (Centers for Disease Control, Hospital, Others).
The Malaria Rapid Diagnostic Devices Market in 2024 plays a pivotal role in combating the global burden of malaria by enabling rapid and accurate diagnosis of the disease in resource-limited settings. Malaria rapid diagnostic tests (RDTs) utilize antigen detection assays to identify Plasmodium parasites in patient blood samples, offering rapid results within minutes without the need for specialized laboratory equipment. The market witnesses significant growth driven by increasing malaria incidence rates, expanding access to healthcare services, and regulatory initiatives promoting the adoption of RDTs as frontline diagnostic tools. Moreover, technological advancements in RDT design, sensitivity, and specificity further bolster market expansion, facilitating early case detection, prompt treatment initiation, and effective disease management strategies.
The global Malaria Rapid Diagnostic Devices Industry is highly competitive with a large number of companies focusing on niche market segments. Amidst intense competitive conditions, Malaria Rapid Diagnostic Devices Companies are investing in new product launches and strengthening distribution channels. Key companies operating in the Malaria Rapid Diagnostic Devices Industry include- Abbott Laboratories, Atomo Diagnostics, bioMérieux SA, Bio-Rad Laboratories Inc, BIOSYNEX SA, Drucker Diagnostics, ERADA Technology Alliance, Omega Diagnostics Group Plc, QIAGEN N.V., SD Biosensor Inc.
A prominent trend in the market for malaria rapid diagnostic devices is the increasing adoption of point-of-care testing (POCT) solutions for the diagnosis of malaria, particularly in resource-limited settings. Point-of-care diagnostic devices offer rapid and accurate detection of malaria parasites directly at the patient's bedside or in community healthcare settings, enabling timely initiation of treatment and reducing the burden on centralized laboratory facilities. With the global efforts to combat malaria and achieve universal access to malaria diagnosis and treatment, there is a growing emphasis on decentralized diagnostic approaches that can reach remote and underserved populations. Rapid diagnostic tests (RDTs) for malaria, based on immunochromatographic assays detecting specific malaria antigens in blood samples, have emerged as indispensable tools for frontline healthcare workers and community health volunteers in malaria-endemic regions. Recent advancements in RDT technology, including improved sensitivity, specificity, and ease of use, have further facilitated the widespread adoption of POCT solutions for malaria diagnosis, driving market growth and expansion of access to malaria testing in resource-limited settings.
The market for malaria rapid diagnostic devices is driven by global malaria control initiatives aimed at reducing the burden of malaria and achieving elimination goals worldwide. Malaria remains a major public health challenge, particularly in sub-Saharan Africa, where the majority of malaria cases and deaths occur. In response to this global health threat, governments, international organizations, and non-governmental organizations have launched ambitious malaria control programs focusing on prevention, diagnosis, and treatment interventions. Key components of these malaria control initiatives include widespread distribution of insecticide-treated bed nets, indoor residual spraying of insecticides, and prompt diagnosis and treatment of malaria cases using rapid diagnostic tests and artemisinin-based combination therapies. The increased funding and support for malaria control programs, coupled with the adoption of innovative diagnostic technologies, have contributed to significant gains in malaria control and reduction of malaria-related morbidity and mortality in endemic regions. This drives market demand for malaria rapid diagnostic devices, as they play a crucial role in the frontline detection and management of malaria cases, supporting the goals of malaria control and elimination efforts worldwide.
A Market Opportunity in the market for malaria rapid diagnostic devices lies in the development of multiplexed diagnostic platforms capable of detecting multiple malaria parasite species and differentiating between drug-resistant strains. While current rapid diagnostic tests (RDTs) primarily target the detection of Plasmodium falciparum, the most deadly malaria parasite species, there is a growing need for diagnostic assays that can also detect other Plasmodium species, such as Plasmodium vivax, Plasmodium ovale, and Plasmodium malariae, which contribute to a significant proportion of malaria cases globally. Additionally, the emergence of drug-resistant malaria strains poses a threat to malaria control efforts and underscores the importance of surveillance and monitoring of drug resistance markers. Multiplexed diagnostic platforms incorporating molecular assays, such as polymerase chain reaction (PCR) or loop-mediated isothermal amplification (LAMP), can offer enhanced sensitivity and specificity for detecting malaria parasites and drug resistance markers in a single test, enabling comprehensive malaria diagnosis and surveillance. By developing multiplexed diagnostic platforms tailored to the needs of malaria-endemic regions, diagnostic companies and researchers can address unmet diagnostic challenges, improve the accuracy of malaria diagnosis, and support evidence-based treatment decisions, ultimately contributing to the global efforts to control and eliminate malaria. Collaboration between public health agencies, diagnostic manufacturers, and research institutions can accelerate the development and validation of multiplexed diagnostic platforms for malaria, unlocking new opportunities for market differentiation and technological innovation in malaria diagnostics.
In the realm of Malaria Rapid Diagnostic Devices, the category experiencing fast growth is the "Systems" segment. Malaria remains a significant global health concern, particularly in regions with limited access to healthcare facilities and laboratory infrastructure. Rapid diagnostic systems play a crucial role in early and accurate diagnosis, enabling prompt treatment and reducing transmission rates. These systems typically include test kits and accompanying instruments for the rapid detection of malaria parasites in blood samples. With advancements in technology, these diagnostic systems are becoming more user-friendly, portable, and capable of delivering quick results, making them invaluable tools in resource-limited settings. The increasing focus on malaria control and elimination efforts worldwide further drives the demand for efficient and reliable diagnostic systems, positioning the "Systems" category for substantial growth in the Malaria Rapid Diagnostic Devices market.
By Category
Consumables
Systems
By Application
Centers for Disease Control
Hospital
Others
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
Abbott Laboratories
Atomo Diagnostics
bioMérieux SA
Bio-Rad Laboratories Inc
BIOSYNEX SA
Drucker Diagnostics
ERADA Technology Alliance
Omega Diagnostics Group Plc
QIAGEN N.V.
SD Biosensor Inc
* List not Exhaustive
• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Malaria Rapid Diagnostic Devices Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Malaria Rapid Diagnostic Devices Industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.
TABLE OF CONTENTS
1 Introduction to 2024 Malaria Rapid Diagnostic Devices Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Analyzed
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain
2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations
3 Executive Summary
3.1 Global Malaria Rapid Diagnostic Devices Market Size Outlook, $ Million, 2021 to 2030
3.2 Malaria Rapid Diagnostic Devices Market Outlook by Type, $ Million, 2021 to 2030
3.3 Malaria Rapid Diagnostic Devices Market Outlook by Product, $ Million, 2021 to 2030
3.4 Malaria Rapid Diagnostic Devices Market Outlook by Application, $ Million, 2021 to 2030
3.5 Malaria Rapid Diagnostic Devices Market Outlook by Key Countries, $ Million, 2021 to 2030
4 Market Dynamics
4.1 Key Driving Forces of Malaria Rapid Diagnostic Devices Industry
4.2 Key Market Trends in Malaria Rapid Diagnostic Devices Industry
4.3 Potential Opportunities in Malaria Rapid Diagnostic Devices Industry
4.4 Key Challenges in Malaria Rapid Diagnostic Devices Industry
5 Market Factor Analysis
5.1 Value Chain Analysis
5.2 Competitive Landscape
5.2.1 Global Malaria Rapid Diagnostic Devices Market Share by Company (%), 2023
5.2.2 Product Offerings by Company
5.3 Porter’s Five Forces Analysis
5.4 Pricing Analysis and Outlook
6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts
7 Global Malaria Rapid Diagnostic Devices Market Outlook by Segments
7.1 Malaria Rapid Diagnostic Devices Market Outlook by Segments, $ Million, 2021- 2030
By Category
Consumables
Systems
By Application
Centers for Disease Control
Hospital
Others
8 North America Malaria Rapid Diagnostic Devices Market Analysis and Outlook To 2030
8.1 Introduction to North America Malaria Rapid Diagnostic Devices Markets in 2024
8.2 North America Malaria Rapid Diagnostic Devices Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Malaria Rapid Diagnostic Devices Market size Outlook by Segments, 2021-2030
By Category
Consumables
Systems
By Application
Centers for Disease Control
Hospital
Others
9 Europe Malaria Rapid Diagnostic Devices Market Analysis and Outlook To 2030
9.1 Introduction to Europe Malaria Rapid Diagnostic Devices Markets in 2024
9.2 Europe Malaria Rapid Diagnostic Devices Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Malaria Rapid Diagnostic Devices Market Size Outlook by Segments, 2021-2030
By Category
Consumables
Systems
By Application
Centers for Disease Control
Hospital
Others
10 Asia Pacific Malaria Rapid Diagnostic Devices Market Analysis and Outlook To 2030
10.1 Introduction to Asia Pacific Malaria Rapid Diagnostic Devices Markets in 2024
10.2 Asia Pacific Malaria Rapid Diagnostic Devices Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Malaria Rapid Diagnostic Devices Market size Outlook by Segments, 2021-2030
By Category
Consumables
Systems
By Application
Centers for Disease Control
Hospital
Others
11 South America Malaria Rapid Diagnostic Devices Market Analysis and Outlook To 2030
11.1 Introduction to South America Malaria Rapid Diagnostic Devices Markets in 2024
11.2 South America Malaria Rapid Diagnostic Devices Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Malaria Rapid Diagnostic Devices Market size Outlook by Segments, 2021-2030
By Category
Consumables
Systems
By Application
Centers for Disease Control
Hospital
Others
12 Middle East and Africa Malaria Rapid Diagnostic Devices Market Analysis and Outlook To 2030
12.1 Introduction to Middle East and Africa Malaria Rapid Diagnostic Devices Markets in 2024
12.2 Middle East and Africa Malaria Rapid Diagnostic Devices Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Malaria Rapid Diagnostic Devices Market size Outlook by Segments, 2021-2030
By Category
Consumables
Systems
By Application
Centers for Disease Control
Hospital
Others
13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
Abbott Laboratories
Atomo Diagnostics
bioMérieux SA
Bio-Rad Laboratories Inc
BIOSYNEX SA
Drucker Diagnostics
ERADA Technology Alliance
Omega Diagnostics Group Plc
QIAGEN N.V.
SD Biosensor Inc
14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise
By Category
Consumables
Systems
By Application
Centers for Disease Control
Hospital
Others
The global Malaria Rapid Diagnostic Devices Market is one of the lucrative growth markets, poised to register a 5.6% growth (CAGR) between 2024 and 2030.
Emerging Markets across Asia Pacific, Europe, and Americas present robust growth prospects.
Abbott Laboratories, Atomo Diagnostics, bioMérieux SA, Bio-Rad Laboratories Inc, BIOSYNEX SA, Drucker Diagnostics, ERADA Technology Alliance, Omega Diagnostics Group Plc, QIAGEN N.V., SD Biosensor Inc
Base Year- 2023; Estimated Year- 2024; Historic Period- 2018-2023; Forecast period- 2024 to 2030; Currency: USD; Volume